Fidaxomicin: A new fight against clostridium difficile-associated diarrhea

Fidaxomicin: A new fight against clostridium difficile-associated diarrhea

Clostridium difficile-associated diarrhea (CDAD) occurs commonly as a side effect of broad-spectrum antibiotics. Drugs approved for CDAD are only two of them, metronidazole and vancomycin. Most promising drug for treatment of CDAD is vancomycin, but due to emergence of hypervirulent strains, outcome...

Full description

Bibliographic Details
Main Authors: Dick B. S. Brashier, Amol Khanapure, A K Sharma
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Muller Journal of Medical Sciences and Research
Subjects:
Clostridium deficits associated diarrhoea
Fidaxomicin
metronidazole
vancomycin
Online Access:http://www.mjmsr.net/article.asp?issn=0975-9727;year=2014;volume=5;issue=2;spage=152;epage=154;aulast=Brashier

Internet

http://www.mjmsr.net/article.asp?issn=0975-9727;year=2014;volume=5;issue=2;spage=152;epage=154;aulast=Brashier

Similar Items